Related Experiment Video

Updated: Jun 2, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562

João Agostinho Machado-Neto1, Patricia Favaro, Mariana Lazarini

  • 1Hematology and Hemotherapy Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil.

Biochimica Et Biophysica Acta
|May 17, 2011
PubMed

Insights

Insulin receptor substrate 1 (IRS1) silencing in BCR-ABL positive K562 cells inhibits proliferation and colony formation. IRS1 inhibition downregulates key signaling pathways, impacting the cell cycle without affecting apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • BCR-ABL kinase is a key driver in Chronic Myeloid Leukemia (CML).
  • IRS1 is implicated in BCR-ABL signaling pathways, showing constitutive phosphorylation in K562 cells.
  • Understanding IRS1's role is crucial for developing targeted CML therapies.

Purpose of the Study:

  • To investigate the functional role of IRS1 in BCR-ABL signaling within K562 cells.
  • To determine the impact of IRS1 silencing on cell proliferation, cell cycle, and key signaling pathways.

Main Methods:

  • Utilized shRNA-lentiviral delivery for IRS1 silencing in K562 cells.
  • Assessed cell proliferation, colony formation, and cell cycle progression (G0/G1, S phases).
  • Analyzed phosphorylation levels of Akt, P70S6K, ERK1/2, BCR-ABL, and CRKL via Western blotting.

Main Results:

  • IRS1 silencing significantly decreased K562 cell proliferation and colony formation.
  • Silencing led to cell cycle delay at G0/G1 phase and reduced S phase entry.
  • IRS1 knockdown reduced phosphorylation of Akt, P70S6K, and ERK1/2, indicating downstream pathway inhibition.

Conclusions:

  • IRS1 functions downstream of BCR-ABL and plays a critical role in regulating proliferation and clonogenicity.
  • Inhibition of IRS1 effectively downregulates the Akt/mTOR and MAPK pathways in BCR-ABL positive cells.
  • Targeting IRS1 presents a potential therapeutic strategy for CML by impacting cell cycle progression.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...